Dividend growth rates over a 5-year or longer period can be a good indicator of strong growth potential in picking a stock ...

It is hard to get excited after looking at Abbott Laboratories' (NYSE:ABT) recent performance, when its stock has declined 5.8% over the past month. However, a closer look at its sound financials ...

You should have around $100 or so remaining from your initial $350 after buying one share each of AbbVie and Dominion Energy.

Every investor in Abbott Laboratories (NYSE:ABT) should be aware of the most powerful shareholder groups. And the group that holds the biggest piece of the pie are institutions with 80% ownership. In ...

When torn between Envista (NVST) and Abbott (ABT) for the best value stock, one shines brighter. Envista flaunts a more appealing forward P/E ratio of 18.81 compared to Abbott's 24.16. Not just the ...

The Roborock Saros Z70's robot arm grabbed headlines, but if you want to spend less time cleaning your home, look at robot ...

But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. There are plenty of strategies for discovering value stocks, but we have found ...

BTIG Research recently trimmed its price target on Abbott Laboratories from $148.00 to $145.00, still maintaining a "buy" ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

Stocks are slightly higher in early trade as earnings, Fed signals, and a cooler tone on trade tensions help steady sentiment ...

Abbott forecasts an adjusted operating margin of approximately 23.5% of sales, down from prior guidance of 23.5%- 24.0%. Abbott expected third-quarter 2025 adjusted earnings of $1.28-$1.32 per share, ...